Dolutegravir + Abacavir + Lamivudine
Form: Tablet
Strength: 50 mg / 600 mg / 300 mg
Reference Brands: Triumeq(US & EU)
Category: Anti Viral
Dolutegravir + Abacavir + Lamivudine is a fixed-dose combination antiretroviral medication used for the treatment of HIV-1 infection. Marketed under the brand name Triumeq, this once-daily oral tablet combines Dolutegravir (an integrase inhibitor), Abacavir, and Lamivudine (both NRTIs) to block HIV replication and reduce viral load. Approved by the US FDA and EMA, it is recommended for adults and adolescents who are HLA-B*5701 negative, with no resistance to any of the components. Triumeq simplifies HIV treatment by combining three powerful agents in one pill, offering high efficacy, strong viral suppression, and improved adherence for long-term HIV management.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Zanamivir
Strength: 5 mg/blister
Form: Inhalation powder
Reference Brands: Relenza(EU & US)
View Details Get Enquiry
Oseltamivir Phosphate Capsule
Strength: Capsule- 30 mg, 45 mg, 75 mg; Oral Suspension - 6 mg/mL (reconstituted)
Form: Capsules and Oral solution
Reference Brands: Tamiflu(EU & US)
View Details Get Enquiry
Amantadine
Strength: Tab -100 mg; Capsule- 100 mg; Oral solution - 50 mg/5 mL; Extended-release capsule (ER) - 129 mg, 193 mg
Form: Tablet; Capsule; Oral Solution and ER Capsule
Reference Brands: Symmetrel(EU & US); Osmolex ER(US), Gocovri(US)
View Details Get Enquiry
Glecaprevir + Pibrentasvir
Strength: Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View Details Get Enquiry